CN111351866A - Method for detecting hyodeoxycholic acid in Xihuang capsules - Google Patents

Method for detecting hyodeoxycholic acid in Xihuang capsules Download PDF

Info

Publication number
CN111351866A
CN111351866A CN201811567159.6A CN201811567159A CN111351866A CN 111351866 A CN111351866 A CN 111351866A CN 201811567159 A CN201811567159 A CN 201811567159A CN 111351866 A CN111351866 A CN 111351866A
Authority
CN
China
Prior art keywords
solution
sample
test
hyodeoxycholic acid
xihuang
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811567159.6A
Other languages
Chinese (zh)
Inventor
谢秋芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebei Wanbang Folon Pharmaceutical Co ltd
Original Assignee
Hebei Wanbang Folon Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei Wanbang Folon Pharmaceutical Co ltd filed Critical Hebei Wanbang Folon Pharmaceutical Co ltd
Priority to CN201811567159.6A priority Critical patent/CN111351866A/en
Publication of CN111351866A publication Critical patent/CN111351866A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/74Optical detectors

Landscapes

  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

The invention provides a method for detecting hyodeoxycholic acid in Xihuang capsules, thereby effectively controlling the product quality.

Description

Method for detecting hyodeoxycholic acid in Xihuang capsules
Technical Field
The invention relates to the technical field of drug detection, in particular to a method for detecting hyodeoxycholic acid in Xihuang capsules by using high performance liquid chromatography.
Background
In the state of the food and drug administration, the West yellow capsule is collected in the national drug Standard WS3And each particle is 0.25 g-B-3210-98-2016, under the condition of the original system in the standard, the separation degree problem exists, the number of interference peaks is large, the result judgment is influenced, and the detection method is formulated for better controlling the product quality.
Disclosure of Invention
The technical problem to be solved by the invention is to design a detection method for detecting hyodeoxycholic acid in Xihuang capsules, so that the product quality is effectively controlled.
The invention provides a detection method for hyodeoxycholic acid in Xihuang capsules.
The object of the invention can be achieved by the following scheme:
instrument, reagent and test article
An Agilent 1260 high performance liquid chromatograph; shimadzu Inertsil ODS-3C18 column (4.6 μm 250mm, 5 μm)
The reagent acetonitrile is chromatographic grade reagent, and other reagents are analytical pure reagents. The water is purified water
Control hyodeoxycholic acid 111845-
Xihuang capsule 18061271807105180713318081011808110 for test
Chromatographic conditions and system applicability test:
high performance liquid chromatograph Agilent 1260
Chromatographic Shimadzu Inertsil ODS-3C18 column (4.6 μm 250mm, 5 μm)
Mobile phase acetonitrile-0.5% formic acid solution (35: 65)
Flow rate 0.8 ml/min-1
Column temperature 30 deg.C
The spraying temperature of the evaporation light scattering detector is 35 ℃, and the temperature of the drift tube is 80 DEG C
The theoretical plate number is not lower than 4000 calculated according to the peak of hyodeoxycholic acid.
Second, test methods and results
(1) Preparation of test solution about 2g of the content of the product under the condition of different loading amount is taken, precisely weighed, added with 40ml of methanol, ultrasonically treated for 40 minutes, cooled, filtered, the filtrate is evaporated to dryness, the residue is added with a proper amount of methanol to dissolve and is transferred to a 10ml measuring flask, added with methanol to scale, shaken evenly and filtered, and the subsequent filtrate is taken as the test solution.
(2) Preparation of control solution A hyodeoxycholic acid control solution was prepared by adding methanol to obtain a solution containing 0.2mg per 1ml as a control solution.
(3) The determination method comprises precisely sucking 10 μ l of each of the reference solution and the sample solution, injecting into high performance liquid chromatograph, and determining.
And thirdly, in the chromatogram of the technical standard test sample, a chromatographic peak which is the same as the retention time of the hyodeoxycholic acid control sample cannot be presented.
Fourthly, the feasibility of the method can be illustrated by the following tests
Investigation of linear relationships
Precisely sucking 1, 2, 3, 4 and 5 mu l of hyodeoxycholic acid control solution (0.2064 mg/ml) respectively, injecting the solution into a high performance liquid chromatograph, measuring, and performing linear regression on peak area (Y) by using mass concentration (x), wherein the regression equation is Y =122.7x-1.938, R2The result of =0.9978 shows that the linear relationship is good. See fig. 1, 2.
Precision survey
Precisely sucking 10 μ l of hyodeoxycholic acid control solution (0.2064 mg/ml), and repeating the sample injection for 5 times, wherein the peak area RSD is 2.66%, and the precision is good. The results are shown in FIG. 3.
Specialization inspection
Sample adding test solution preparation: sucking 5ml of each of the sample solution and the reference solution, mixing in a 10ml measuring flask, filtering, and collecting the filtrate.
Precisely sucking 10 mul of a control solution and 10 mul, 15 mul, 20 mul and 30 mul of a test solution into a high performance liquid chromatograph respectively by a measuring method, and measuring a result: the sample does not have chromatographic peak at the same retention time as the hyodeoxycholic acid control, and the labeled sample has peak at the same retention time as the control, thus proving good specificity. The results are shown in FIG. 4.
Durability test
Preparation of test solution: weighing 1808109 batches of 2.0079g of Xihuang capsules, 1808110 batches of 2.0163g of Xihuang capsules, 1807133 batches of 2.0099g of Xihuang capsules and 1806127 batches of 2.0234g of Xihuang capsules, and preparing a test solution according to a preparation method of the test solution.
Using a Watts Waters symmetry purified RP18 type C18 (No. LC-016) (4.6X 250), and Shimadzu Inertsil ODS-3 type C18 (No. LC-008) (4.6X 250) chromatographic columns, 10. mu.l of the sample was precisely injected under the above chromatographic conditions, and detection was carried out. As a result, 2 chromatographic columns of different brands are well separated, and no interference peak exists near a target peak in the chromatogram of the test sample. The results are shown in FIG. 5.
Drawings
The determination method has strong specificity, and the linearity, the precision and the durability of the method all meet better technical requirements. The method can effectively control the quality of the Xihuang capsule product.
FIG. 1 is a graph of results of a linear relationship investigation; FIG. 2 is a linear trend graph; FIG. 3 is a graph showing the results of precision examination; FIG. 4 is a diagram of results of a specificity study; FIG. 5 is a graph showing the result of durability test.
Detailed Description
Instrument, reagent and test article
An Agilent 1260 high performance liquid chromatograph; shimadzu Inertsil ODS-3C18 column (4.6 μm 250mm, 5 μm)
The reagent acetonitrile is chromatographic grade reagent, and other reagents are analytical pure reagents. The water is purified water
Control hyodeoxycholic acid 111845-
Xihuang capsule 18071051806127180713318081011808110 for test
Test method and results
High performance liquid chromatography is adopted.
Chromatographic conditions and system applicability test:
high performance liquid chromatograph Agilent 1260
Chromatographic Shimadzu Inertsil ODS-3C18 column (4.6 μm 250mm, 5 μm)
Mobile phase acetonitrile-0.5% formic acid solution (35: 65)
Flow rate 0.8 ml/min-1
Column temperature 30 deg.C
The spraying temperature of the evaporation light scattering detector is 35 ℃, and the temperature of the drift tube is 80 DEG C
The theoretical plate number is not lower than 4000 calculated according to the peak of hyodeoxycholic acid.
(1) Preparation of test solution about 2g of the content of the product under the condition of different loading amount is taken, precisely weighed, added with 40ml of methanol, ultrasonically treated for 40 minutes, cooled, filtered, the filtrate is evaporated to dryness, the residue is added with a proper amount of methanol to dissolve and is transferred to a 10ml measuring flask, added with methanol to scale, shaken evenly and filtered, and the subsequent filtrate is taken as the test solution.
(2) Preparation of control solution A hyodeoxycholic acid control solution was prepared by adding methanol to obtain a solution containing 0.2mg per 1ml as a control solution.
(3) The determination method comprises precisely sucking 10 μ l of each of the reference solution and the sample solution, injecting into high performance liquid chromatograph, and determining.
The chromatogram of the test sample does not show a chromatographic peak with the same retention time as that of the hyodeoxycholic acid control.

Claims (3)

1. A method for detecting hyodeoxycholic acid in Xihuang capsules is characterized by comprising the following steps:
preparing a test solution, precisely weighing about 2g of the content of the product under the condition of different loading amounts, adding 40ml of methanol, performing ultrasonic treatment for 40 minutes, cooling, filtering, evaporating filtrate, dissolving residue in a proper amount of methanol, transferring to a 10ml measuring flask, adding methanol to scale, shaking up, filtering, and taking a subsequent filtrate as the test solution;
preparing a control solution by adding methanol into hyodeoxycholic acid control to obtain a solution containing 0.2mg per 1ml as the control solution;
the liquid chromatography condition and system applicability test is tested by high performance liquid chromatography, and octadecylsilane chemically bonded silica is used as a filler; acetonitrile-0.5% formic acid solution (35: 65) is used as a mobile phase; flow rate: 0.8 ml/min-1(ii) a Column temperature: 30 ℃; evaporating a light scattering detector, wherein the spraying temperature is 35 ℃, and the drift tube temperature is 80 ℃;
the number of theoretical plates is not less than 4000 calculated according to the peak of hyodeoxycholic acid;
the determination method comprises precisely sucking 10 μ l of each of the reference solution and the sample solution, injecting into high performance liquid chromatograph, and determining.
2. The detection method according to claim 1, characterized in that chromatographic conditions and system suitability tests of the method;
octadecyl bonded silica gel is used as a filling agent; acetonitrile-0.5% formic acid solution (35: 65) as mobile phase; flow rate: 0.8 ml/min-1(ii) a Column temperature: 30 ℃; evaporating a light scattering detector, wherein the spraying temperature is 35 ℃, and the drift tube temperature is 80 ℃;
the theoretical plate number is not lower than 4000 calculated according to the peak of hyodeoxycholic acid;
the determination method comprises precisely sucking 10 μ l of each of the reference solution and the sample solution, injecting into high performance liquid chromatograph, and determining.
3. The test method according to claim 1, characterized in that the test result of the method is that chromatographic peaks of the sample of the Xihuang capsule cannot be shown in the sample chromatogram of the sample, and the chromatographic peaks can not be shown in the sample chromatogram of the sample of the Hehyodeoxycholic acid.
CN201811567159.6A 2018-12-20 2018-12-20 Method for detecting hyodeoxycholic acid in Xihuang capsules Pending CN111351866A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811567159.6A CN111351866A (en) 2018-12-20 2018-12-20 Method for detecting hyodeoxycholic acid in Xihuang capsules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811567159.6A CN111351866A (en) 2018-12-20 2018-12-20 Method for detecting hyodeoxycholic acid in Xihuang capsules

Publications (1)

Publication Number Publication Date
CN111351866A true CN111351866A (en) 2020-06-30

Family

ID=71195626

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811567159.6A Pending CN111351866A (en) 2018-12-20 2018-12-20 Method for detecting hyodeoxycholic acid in Xihuang capsules

Country Status (1)

Country Link
CN (1) CN111351866A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115201357A (en) * 2022-06-17 2022-10-18 陕西盘龙医药研究院 Limit detection method for hyodeoxycholic acid in infantile pharyngeal flattening granules

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101332287A (en) * 2008-06-25 2008-12-31 浙江永宁药业股份有限公司 Quality control method of Danle capsule
CN104090056A (en) * 2014-06-27 2014-10-08 上海雷允上药业有限公司 Method for determining content of hyodeoxycholic acid in Beiling capsules through HPLC (High Performance Liquid Chromatography)-ELSD (Evaporative Light Scattering Detector) method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101332287A (en) * 2008-06-25 2008-12-31 浙江永宁药业股份有限公司 Quality control method of Danle capsule
CN104090056A (en) * 2014-06-27 2014-10-08 上海雷允上药业有限公司 Method for determining content of hyodeoxycholic acid in Beiling capsules through HPLC (High Performance Liquid Chromatography)-ELSD (Evaporative Light Scattering Detector) method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
国家药典委员会: "西黄丸", 《中华人民共和国药典2015年版》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115201357A (en) * 2022-06-17 2022-10-18 陕西盘龙医药研究院 Limit detection method for hyodeoxycholic acid in infantile pharyngeal flattening granules

Similar Documents

Publication Publication Date Title
CN110646550B (en) Method for detecting related substances in atorvastatin calcium
CN111855842B (en) Detection method and application of related substances of ozagrel sodium
CN107449846B (en) Method for measuring effective components in infantile nerve-soothing and brain-nourishing granules by HPLC-MS (high Performance liquid chromatography-Mass Spectrometry)
CN104849369B (en) The attached sweet drug quality detection method of a kind of fiber crops
CN107515255B (en) Method for measuring dapagliflozin and related substances thereof by using high performance liquid chromatograph
CN112034060A (en) Analysis method of pantoprazole sodium related substance for injection
CN109900830B (en) Method for separating and determining sulfonamide impurities in celecoxib by adopting HPLC (high performance liquid chromatography) and application
CN105467021B (en) A kind of method in relation to substance in HPLC method separation determination paricalcitol bulk pharmaceutical chemicals and preparation
CN109387587B (en) Detection method of L-2-amino-5-guanidino valeric acid enantiomer
CN111351866A (en) Method for detecting hyodeoxycholic acid in Xihuang capsules
CN107764908A (en) A kind of method for determining alkaloid component content in blood-nourishing and brain-refreshing the water extracted immersing paste
CN106706769B (en) Separation and determination method of empagliflozin and optical isomer thereof
CN114689737B (en) Analysis method of S-o-chlorophenylglycine methyl tartrate related substances
CN101393181A (en) Method for measuring relative material of sodium divalproate
CN104897832A (en) High performance liquid chromatography method for detecting free amino acid content in transfer factor solution and preparation thereof
CN101609070A (en) A kind of method of measuring related substances of losastan potassium/hydrochlorothiazide tablets with HPLC
CN106153756B (en) High performance liquid chromatography for detecting rapamycin in everolimus
CN111189937B (en) Liquid phase detection separation method for related substances of aspirin bulk drug
CN106290600B (en) A method of with liquid chromatography, separation health Buddhist nun replaces Buddhist nun and related substance
CN108226354A (en) A kind of detection method of budesonide residual solvent
CN110412164B (en) Method for detecting related substances of mexiletine hydrochloride
CN106290625A (en) A kind of dirithromycin raw material has the detection method of related substance
CN112067709A (en) Method for determining cefodizime sodium related substance for injection and application
CN109265496A (en) A kind of synthetic method of glucoside-containing component
CN110133168A (en) HPLC method measures method of the Cabazitaxel in relation to substance

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200630